Life Sciences Maste Perceptive's Net Worth

Life Sciences Maste Perceptive's net worth is estimated to be at least $236,646,034.22 as of 02/09/2023. CoreStreet's estimation of Life Sciences Maste Perceptive's net worth is based on their sale of stock and current holding of stock.

Life Sciences Maste Perceptive is Major Shareholder at Albireo Pharma Inc. They have executed at least 30 trades of stock as per SEC Form 4 filings. Their most recent trade was for 400,000 units of ALBO stock on 09/14/2020. Their biggest sale was on 06/19/2017 when they sold 875,000 units of AcelRx Pharmaceuticals Inc stock for $2,100,000.00. They typically trade 7 times per year.

Total value of insider buys:
  • $234,456,445.82
Total value of insider sells:
  • $2,189,588.40
Most recent insider trade:
  • Sept. 14, 2020

Life Sciences Maste Perceptive's Insider Trading History

Albireo Pharma IncTitleAmountPriceTypeTotal Value
Sept. 14, 2020
Major Shareholder400,000$40.00Buy$16,000,000.00
Jan. 25, 2018
Major Shareholder275,000$33.00Buy$9,075,000.00
VBI Vaccines IncTitleAmountPriceTypeTotal Value
April 24, 2020
Major Shareholder9,090,909$1.21Buy$10,999,999.89
June 17, 2019
Major Shareholder1,000,000$0.62Buy$620,000.00
Oct. 26, 2017
Major Shareholder3,100,000$3.05Buy$9,455,000.00
Agile ThrpeTitleAmountPriceTypeTotal Value
Feb. 25, 2020
Major Shareholder3,000,000$3.02Buy$9,060,000.00
July 26, 2018
Insider298,628$0.30Sell$89,588.40
Athenex IncTitleAmountPriceTypeTotal Value
Dec. 23, 2019
Major Shareholder606,302$14.54Buy$8,815,631.08
Aug. 8, 2019
Major Shareholder808,481$14.67Buy$11,860,416.27
June 17, 2019
Major Shareholder130,000$17.94Buy$2,332,200.00
June 13, 2019
Major Shareholder75,710$17.05Buy$1,290,855.50
MeiraGTx Holdings PLCTitleAmountPriceTypeTotal Value
Aug. 12, 2019
Director425,531$23.50Buy$9,999,978.50
March 1, 2019
Major Shareholder1,304,348$13.80Buy$18,000,002.40
June 12, 2018
Director1,383,333$15.01Buy$20,763,828.33
Solid Biosciences LLCTitleAmountPriceTypeTotal Value
July 25, 2019
Director2,822,581$4.65Buy$13,125,001.65
Jan. 30, 2018
Director1,020,000$16.22Buy$16,544,400.00
Motus GI Holdings IncTitleAmountPriceTypeTotal Value
June 27, 2019
Major Shareholder1,000,000$3.00Buy$3,000,000.00
Feb. 16, 2018
Major Shareholder1,000,000$5.00Buy$5,000,000.00
ADMA Biologics IncTitleAmountPriceTypeTotal Value
May 21, 2019
Major Shareholder4,000,000$4.00Buy$16,000,000.00
Quotient LtdTitleAmountPriceTypeTotal Value
Dec. 7, 2018
Major Shareholder2,000,000$6.50Buy$13,000,000.00
May 23, 2018
Major Shareholder450,000$6.45Buy$2,902,500.00
Amicus Therapeutics IncTitleAmountPriceTypeTotal Value
Oct. 3, 2018
Major Shareholder50,000$12.59Buy$629,500.00
Sept. 21, 2018
Major Shareholder50,000$12.53Buy$626,500.00
Sept. 12, 2018
Major Shareholder500,000$12.00Buy$6,000,000.00
March 1, 2018
Major Shareholder100,000$13.69Buy$1,369,000.00
July 13, 2017
Major Shareholder1,500,000$12.25Buy$18,375,000.00
Crinetics Pharmaceuticals IncTitleAmountPriceTypeTotal Value
July 20, 2018
Director400,000$17.00Buy$6,800,000.00
Aldeyra TheTitleAmountPriceTypeTotal Value
Sept. 19, 2017
Major Shareholder200,000$7.25Buy$1,450,000.00
June 30, 2017
Major Shareholder296,007$4.60Buy$1,361,632.20
AcelRx Pharmaceuticals IncTitleAmountPriceTypeTotal Value
June 19, 2017
Major Shareholder875,000$2.40Sell$2,100,000.00